MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Novel familial HPCA mutation associated with autosomal recessive dystonia: Strengthening the role of HPCA in hereditary movement disorders.

    S. Siegert, W. Schmidt, R. Bittner, S. Gobara, M. Freilinger (Vienna, Austria)

    Objective: The objective was to describe the genetic and clinical findings in a Turkish girl, her father and paternal uncle carrying a novel homozygous HPCA…
  • 2019 International Congress

    Cerebellar brain inhibition and cervical dystonia: exploring clinico-electrophysiological associations

    R. Sondergaard, LS. Gan, Y. Jasaui, J. Sarna, S. Furtado, T. Pringsheim, D. Martino (Calgary, AB, Canada)

    Objective: To examine the association between clinical features of cervical dystonia (CD) and cerebellar inhibition of the motor cortex (M1). Background: The involvement of cerebellar…
  • 2019 International Congress

    Clinical Applications of Non-Invasive Neuromodulation associated with kinesiotherapy in focal dystonia patients: report of three cases

    C. Souza, J. Goulardins, D. Boari, S. Casagrande, J. Papaterra, C. Boffino, C. Tanaka, K. Monte-Silva (Sao Paulo, Brazil)

    Objective: The aim of our study was to evaluate further the potential role of Non-Invasive Neuromodulation combined with kinesiotherapy for treatment of focal dystonia (FD).…
  • 2019 International Congress

    Physiotherapy in cervical dystonia with focus on clinical assessments on ICF

    M. Steinboeck, H. Unger (Bad Aibling, Germany)

    Objective: It is to assess if the results of the common clinical evaluation of patients with cervical dystonia can be summarized in an objective observation…
  • 2019 International Congress

    Defining biomarkers to discriminate between organic and functional dystonia

    A. Stephan, D. Benninger (Lausanne, Switzerland)

    Objective: Establish methodologies, fast and easy to translate to clinics, that help discriminate between organic and functional dystonia. Background: Functional dystonias are challenging diagnoses that…
  • 2019 International Congress

    Musician’s dystonia: results from a large US case series

    C. Stephen, M. Charness (Boston, MA, USA)

    Objective: We describe the clinical characteristics of a large US cohort of musician’s focal dystonia (MFD), including both amateur and professional musicians. Background: Musician’s focal…
  • 2019 International Congress

    Classification of idiopathic cervical dystonia: an observational study

    P. Tater, N. Sarma, S. Pandey (New Delhi, India)

    Objective: The aim of our study was to classify patients with idiopathic cervical dystonia who had never been injected botulinum toxin. Background: Idiopathic cervical dystonia…
  • 2019 International Congress

    Reduced interhemispheric and premotor-motor connectivity during handwriting in patients with writer’s cramp

    N. Thirugnanasambandam, T. Zimmermann, A. Pillai, J. Shields, S. Horovitz, M. Hallett (Bethesda, MD, USA)

    Objective: In the current study, our aim was to determine if there occurred task-specific changes in functional connectivity within the task-specificity network for handwriting in…
  • 2019 International Congress

    Non-motor symptoms in Myoclonus-Dystonia: a comparison to other dystonia subtypes

    E. Timmers, M. Smit, A. Kuiper, A. Bartels, S. Vander Veen, A. Vander Stouwe, P. Santens, B. Bergmans, M. Tijssen (Groningen, Netherlands)

    Objective: Systematically study NMS in M-D in direct comparison to other types of dystonia and healthy controls. Background: Myoclonus-dystonia (M-D) due to a SGCE mutation…
  • 2019 International Congress

    Effect of Botulinum Toxin Treatment on Cervical Dystonia

    S. Tomic, M. Tomasevic, D. Hardi, T. Gilman Kuric, Z. Popovic (Osijek, Croatia)

    Objective: To find out influence of botulinum toxin (BonT) treatment on improvement of motor symptoms and pain.To find out influence of botulinum toxin (BonT) treatment…
  • « Previous Page
  • 1
  • …
  • 1118
  • 1119
  • 1120
  • 1121
  • 1122
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley